Fundamentals for Fusion Antibodies ( fab )
Current Price: 0.03
Market Cap: 3.19m
Price / Net Assets: 0.87
Internal Rate of Return: 15.58%
PE10 Ratio: -2.38
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | Average |
|---|---|---|---|---|---|---|
| Revenue (m) | £4.8m | £4.16m | £3.9m | £2.18m | £2.69m | £4m |
| Revenue Growth | 15.38% | 6.67% | 78.90% | -18.96% | - | 20% |
| Profit / Loss | £-1.2m | £-2.9m | £-0.7m | £-1.26m | £-0.7m | £-1m |
| Profit Increase/Decrease | -58.62% | 314.29% | -44.44% | 80.00% | - | 73% |
| Profit / Sales Ratio | - | - | - | - | - | 0% |
| Earnings per Share | £-0.05 | £0.00 | £-0.03 | £-0.06 | £-0.04 | £-0.04 |
| Total Debt | £1.23m | £1.08m | £1.23m | £0.89m | £0.63m | £1.01m |
| Net Assets | £3.68m | £4.75m | £4.81m | £5.35m | £6.58m | £5.03m |
| Debt / Asset Ratio | 25.05% | 18.52% | 20.36% | 14.26% | 8.74% | 8.74% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0.00x |